Works matching IS 01145916 AND DT 2021 AND VI 44 AND IP 8

Results: 8

Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position Paper.

Published in:

Drug Safety, 2021, v. 44, n. 8, p. 825, doi. 10.1007/s40264-021-01083-x

By:

Barata, Fernando;
Aguiar, Carlos;
Marques, Tiago Reis;
Marques, José Bravo;
Hespanhol, Venceslau

Publication type:

Article

Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study.

Published in:

2021

By:

Hoffman, Veena;
Hallas, Jesper;
Linder, Marie;
Margulis, Andrea V.;
Suehs, Brandon T.;
Arana, Alejandro;
Phiri, Kelesitse;
Enger, Cheryl;
Horter, Libby;
Odsbu, Ingvild;
Olesen, Morten;
Perez-Gutthann, Susana;
Xu, Yihua;
Kristiansen, Nina Sahlertz;
Appenteng, Kwame;
de Vogel, Stefan;
Seeger, John D.;
the mirabegron PMR-PASS study group;
Seeger, John;
Bahmanyar, Shahram

Publication type:

journal article

Prevalence, Nature, Severity and Preventability of Adverse Drug Events in Mental Health Settings: Findings from the MedicAtion relateD harm in mEntal health hospitals (MADE) Study.

Published in:

Drug Safety, 2021, v. 44, n. 8, p. 877, doi. 10.1007/s40264-021-01088-6

By:

Alshehri, Ghadah H.;
Ashcroft, Darren M.;
Nguyen, Joanne;
Hann, Mark;
Jones, Richard;
Seaton, Kristof;
Newton, Graham;
Keers, Richard N.

Publication type:

Article

Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010-2019.

Published in:

2021

By:

Setyawan, Juliana;
Azimi, Nassir;
Strand, Vibeke;
Yarur, Andres;
Fridman, Moshe

Publication type:

journal article

Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders.

Published in:

Drug Safety, 2021, v. 44, n. 8, p. 853, doi. 10.1007/s40264-021-01081-z

By:

Jonker, Carla J.;
de Vries, Sieta T.;
van den Berg, H. Marijke;
McGettigan, Patricia;
Hoes, Arno W.;
Mol, Peter G. M.

Publication type:

Article

Association Between Prenatal Opioid Exposure and Neurodevelopmental Outcomes in Early Childhood: A Retrospective Cohort Study.

Published in:

Drug Safety, 2021, v. 44, n. 8, p. 863, doi. 10.1007/s40264-021-01080-0

By:

Wen, Xuerong;
Lawal, Oluwadolapo D.;
Belviso, Nicholas;
Matson, Kelly L.;
Wang, Shuang;
Quilliam, Brian J.;
Meador, Kimford J.

Publication type:

Article

Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities.

Published in:

Drug Safety, 2021, v. 44, n. 8, p. 843, doi. 10.1007/s40264-021-01078-8

By:

Kugener, Veronique F.;
Freedland, Eric S.;
Maynard, Kenneth I.;
Aimer, Omar;
Webster, Peggy S.;
Salas, Maribel;
Gossell-Williams, Maxine

Publication type:

Article

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology.

Published in:

Drug Safety, 2021, v. 44, n. 8, p. 835, doi. 10.1007/s40264-021-01074-y

By:

Osborne, Vicki;
Lane, Samantha;
Shakir, Saad A. W.

Publication type:

Article